Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer

Biomed Res Int. 2018 Nov 1:2018:9207153. doi: 10.1155/2018/9207153. eCollection 2018.

Abstract

Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 - 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 - 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / genetics*
  • Carcinoma, Ovarian Epithelial / epidemiology
  • Carcinoma, Ovarian Epithelial / genetics*
  • Disease-Free Survival
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Kaplan-Meier Estimate
  • Middle Aged
  • Prognosis*
  • RNA, Messenger
  • Trans-Activators
  • Transcription Factors / genetics*

Substances

  • Biomarkers, Tumor
  • MACC1 protein, human
  • RNA, Messenger
  • Trans-Activators
  • Transcription Factors